Literature DB >> 11422779

Nitric oxide and the liver.

R Farzaneh-Far1, K Moore.   

Abstract

In recent years, the role of nitric oxide (NO) in the pathogenesis of liver disease and its complications has been extensively studied. There remain, however, many areas of controversy. In particular, the effect of NO on vascular function in the systemic circulation and the hepatic microcirculation has received the greatest attention. It has been proposed on the one hand that increased NO synthesis is responsible for the development of the hyperdynamic circulation in cirrhosis, while decreased production of NO within the hepatic microcirculation may be important in the development of parenchymal tissue damage and the onset of portal hypertension. The purpose of this review is to examine the available data concerning the role of NO in liver disease and to discuss some of the controversies and contradictions that surround it.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11422779     DOI: 10.1034/j.1600-0676.2001.021003161.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  11 in total

1.  Oxidative stress in portal hypertension-induced rats with particular emphasis on nitric oxide and trace metals.

Authors:  Titiz Izzet; Krand Osman; Unal Ethem; Yavuz Nihat; Kusaslan Ramazan; Dogan Mustafa; Uzun Hafize; Kiziler Ali Riza; Aydemir Birsen; Genc Habibe; Aydin Seval; Simsek Gonul
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

2.  Pathogenetic background for treatment of ascites and hepatorenal syndrome.

Authors:  Søren Møller; Jens H Henriksen; Flemming Bendtsen
Journal:  Hepatol Int       Date:  2008-09-20       Impact factor: 6.047

3.  Production of reactive oxygen species and expression of inducible nitric oxide synthase in rat isolated Kupffer cells stimulated by Leptospira interrogans and Borrelia burgdorferi.

Authors:  Antonella Marangoni; Silvia Accardo; Rita Aldini; Massimo Guardigli; Francesca Cavrini; Vittorio Sambri; Marco Montagnani; Aldo Roda; Roberto Cevenini
Journal:  World J Gastroenterol       Date:  2006-05-21       Impact factor: 5.742

4.  Systemic hypertension in two patients with ASL deficiency: a result of nitric oxide deficiency?

Authors:  Nicola Brunetti-Pierri; Ayelet Erez; Oleg Shchelochkov; William Craigen; Brendan Lee
Journal:  Mol Genet Metab       Date:  2009-06-13       Impact factor: 4.797

Review 5.  Cardiopulmonary complications in chronic liver disease.

Authors:  Soren Moller; Jens H Henriksen
Journal:  World J Gastroenterol       Date:  2006-01-28       Impact factor: 5.742

6.  Nitric oxide synthase and heme oxygenase expressions in human liver cirrhosis.

Authors:  Beatrice J Goh; Bee Tee Tan; Wei Min Hon; Kang Hoe Lee; Hoon Eng Khoo
Journal:  World J Gastroenterol       Date:  2006-01-28       Impact factor: 5.742

7.  The role of nitric oxide and ferritin in the pathogenesis of alcoholic liver disease: a controlled clinical study.

Authors:  Azra Husić-Selimović; Jasminko Huskić; Zora Vukobrat-Bijedić; Rusmir Mesihović; Mehmed Gribajcević
Journal:  Bosn J Basic Med Sci       Date:  2009-08       Impact factor: 3.363

8.  Nitric oxide regulates tumor cell cross-talk with stromal cells in the tumor microenvironment of the liver.

Authors:  Ningling Kang Decker; Soha S Abdelmoneim; Usman Yaqoob; Helen Hendrickson; Joe Hormes; Mike Bentley; Henry Pitot; Raul Urrutia; Greg J Gores; Vijay H Shah
Journal:  Am J Pathol       Date:  2008-08-28       Impact factor: 4.307

9.  Significance of enhanced expression of nitric oxide syntheses in splenic sinus lining cells in altered portal hemodynamics of idiopathic portal hypertension.

Authors:  Yasunori Sato; Seiko Sawada; Kazuto Kozaka; Kenichi Harada; Motoko Sasaki; Osamu Matsui; Yasuni Nakanuma
Journal:  Dig Dis Sci       Date:  2007-04-07       Impact factor: 3.487

10.  Adenovirus-mediated eNOS expression augments liver injury after ischemia/reperfusion in mice.

Authors:  Arun P Palanisamy; Gang Cheng; Alton G Sutter; John Liu; David N Lewin; Julie Chao; Kenneth Chavin
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.